Cargando…
Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines
Seasonal influenza epidemics and influenza pandemics caused by influenza A virus (IAV) has resulted in millions of deaths in the world. The development of anti-IAV vaccines and therapeutics is urgently needed for prevention and treatment of IAV infection and for controlling future influenza pandemic...
Autores principales: | Jiang, Shibo, Li, Runming, Du, Lanying, Liu, Shuwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728157/ https://www.ncbi.nlm.nih.gov/pubmed/21203946 http://dx.doi.org/10.1007/s13238-010-0054-6 |
Ejemplares similares
-
Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin
por: Yang, Jie, et al.
Publicado: (2013) -
Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry
por: Wu, Wenjiao, et al.
Publicado: (2015) -
An Induced Pocket for the Binding of Potent Fusion Inhibitor CL-385319 with H5N1 Influenza Virus Hemagglutinin
por: Li, Runming, et al.
Publicado: (2012) -
Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry
por: Du, Ruikun, et al.
Publicado: (2019) -
Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection
por: Guo, Yan, et al.
Publicado: (2017)